A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 19,824 shares of VRTX stock, worth $7.88 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
19,824
Previous 59,511 66.69%
Holding current value
$7.88 Million
Previous $27.9 Million 66.95%
% of portfolio
0.16%
Previous 0.46%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$460.0 - $505.78 $18.3 Million - $20.1 Million
-39,687 Reduced 66.69%
19,824 $9.22 Million
Q2 2024

Aug 14, 2024

SELL
$392.81 - $485.53 $3.53 Million - $4.37 Million
-8,997 Reduced 13.13%
59,511 $27.9 Million
Q1 2024

May 03, 2024

BUY
$407.69 - $446.08 $4.24 Million - $4.64 Million
10,408 Added 17.91%
68,508 $28.6 Million
Q4 2023

Feb 09, 2024

SELL
$343.0 - $410.68 $1.31 Million - $1.56 Million
-3,810 Reduced 6.15%
58,100 $23.6 Million
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $3.61 Million - $3.87 Million
10,673 Added 20.83%
61,910 $21.5 Million
Q2 2023

Aug 03, 2023

SELL
$314.42 - $351.91 $1.58 Million - $1.77 Million
-5,041 Reduced 8.96%
51,237 $18 Million
Q1 2023

May 12, 2023

BUY
$283.23 - $323.1 $1.76 Million - $2.01 Million
6,231 Added 12.45%
56,278 $17.7 Million
Q4 2022

Feb 13, 2023

BUY
$285.76 - $321.48 $1.06 Million - $1.19 Million
3,705 Added 7.99%
50,047 $14.5 Million
Q3 2022

Nov 07, 2022

SELL
$273.83 - $305.53 $2.03 Million - $2.26 Million
-7,408 Reduced 13.78%
46,342 $13.4 Million
Q2 2022

Aug 12, 2022

SELL
$234.96 - $292.55 $3.59 Million - $4.47 Million
-15,296 Reduced 22.15%
53,750 $15.1 Million
Q1 2022

May 11, 2022

SELL
$221.42 - $260.97 $2.18 Million - $2.57 Million
-9,831 Reduced 12.46%
69,046 $18 Million
Q4 2021

Feb 02, 2022

SELL
$177.01 - $223.45 $78,415 - $98,988
-443 Reduced 0.56%
78,877 $17.3 Million
Q3 2021

Nov 09, 2021

BUY
$181.39 - $202.99 $4.28 Million - $4.79 Million
23,573 Added 42.29%
79,320 $14.4 Million
Q2 2021

Aug 06, 2021

SELL
$187.49 - $221.1 $1.01 Million - $1.19 Million
-5,371 Reduced 8.79%
55,747 $11.2 Million
Q1 2021

May 10, 2021

BUY
$207.02 - $241.31 $1.42 Million - $1.65 Million
6,851 Added 12.62%
61,118 $13.1 Million
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $6.31 Million - $8.42 Million
30,501 Added 128.34%
54,267 $12.8 Million
Q3 2020

Nov 09, 2020

BUY
$255.65 - $303.1 $1.47 Million - $1.74 Million
5,757 Added 31.97%
23,766 $6.47 Million
Q2 2020

Aug 05, 2020

BUY
$225.48 - $295.8 $2.73 Million - $3.59 Million
12,128 Added 206.22%
18,009 $5.23 Million
Q1 2020

May 11, 2020

BUY
$199.77 - $247.81 $817,458 - $1.01 Million
4,092 Added 228.73%
5,881 $1.4 Million
Q4 2019

Mar 19, 2020

SELL
$166.71 - $223.91 $59,515 - $79,935
-357 Reduced 16.64%
1,789 $392,000
Q3 2019

Mar 19, 2020

BUY
$166.23 - $187.09 $25,433 - $28,624
153 Added 7.68%
2,146 $364,000
Q2 2019

Mar 19, 2020

BUY
$164.61 - $190.37 $328,067 - $379,407
1,993 New
1,993 $365,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $102B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Bi Asset Management Fondsmaeglerselskab A Portfolio

Follow Bi Asset Management Fondsmaeglerselskab A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

News

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.